Skip to main content

Archived Comments for: DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells

Back to article

  1. The therapeutic target as DACH1, a novel target oncogenic molecule of canonical Wnt signal to regulate cyclinD1 expression

    Go Yoshida, Tokyo Medical and Dental University

    5 November 2014

    Loss of DACH1 expression has been recognized in various types of tumors including breast, prostate, renal, and endometrial cancer. It has been found out that ectopic expression of DACH1 reduces TCF/LEF-dependent beta-catenin transcription activity and then inhibits the expression of Wnt/beta-catenin signaling downstream targets characterized by CD44, c-Myc and cyclinD1. In this research article, the authors have investigated into the epigenetic regulation to induce the inversed expression pattern between cyclinD1 and DACH1. However, it also seems to deserve to be investigated whether CD44 or c-Myc show the inversed expression manner as compared with DACH1.

     

    Ref.

    Epigenetics. 2013;8:1373-83. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.

    Biochem Biophys Res Commun. 2014;443:622-7. Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation.

    Competing interests

    No Competing interests exist.

Advertisement